ALL HYPOTHESES
Repurposing candidates for EGCG-SeNPs
Alzheimer 3
| Mediator | Outcome | Score | Tier | Lit. status | Trial | |
|---|---|---|---|---|---|---|
| GFAP | Alzheimer disease | 0.208 | Mid | novel signal | none | |
| GFAP | cognitive impairment | 0.208 | Mid | novel signal | none | |
| GFAP | cognitive decline | 0.208 | Mid | novel signal | none |
No registered trials found on ClinicalTrials.gov. This could indicate either an unexplored indication or a gap in registry coverage.
Search ClinicalTrials.gov →